Genomic Health, Inc. Information Request Form

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Genomic Health, Inc. (“Genomic Health” or the “Company”) (NASDAQGS: GHDX) to Exact Sciences Corp. (“Exact Sciences”)(NASDAQCM: EXAS). Under the terms of the deal, Genomic Health stockholders will receive $27.50 in cash and $44.50 in shares of Exact Sciences stock (subject to a 10% collar centered on Exact Sciences’ volume-weighted average price for the 45 trading days ended July 26, 2019) for each share of Genomic Health common stock they own.

The Genomic Health merger investigation concerns whether the Board of Genomic Health breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Exact Sciences is underpaying for Genomic Health shares, thus unlawfully harming Genomic Health shareholders.

To receive more information, please fill out the form.

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit.

This submission does not create an attorney-client relationship. If we believe that you might be an appropriate lead plaintiff, we will contact you to discuss whether to establish an attorney-client relationship.

Yes I'd Like to Join Action

This letter confirms that you have retained Levi & Korsinsky, LLP to represent you as a named plaintiff in the class action against Genomic Health, Inc. As a named plaintiff, you acknowledge that you owned shares in Genomic Health, Inc. prior to the recent takeover announcement and that you must maintain ownership in Genomic Health, Inc. throughout the litigation.

We agree to advance all expenses in the litigation, which means that you are not liable to pay any of the expenses of the lawsuit, whether attorneys’ fees or costs. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees or costs. Should we obtain a favorable result, we may ask the court to award us compensation to be paid by the defendants or as a portion of any benefit, but, again, we will never ask you to directly pay any of the costs of this litigation.

As our client, you are entitled to direct the litigation in any way you deem proper, and may at any time order us to dismiss the case. Should you choose to do so, we will never ask you to reimburse us directly for any legal fees or expenses. During the course of this litigation, we may employ and/or work with other law firms to prosecute your case.

We look forward to representing you and other Genomic Health shareholders.

Sincerely,

Levi & Korsinsky,LLP

Joseph Levi

AGREED: Sign Name Clear